SEC Comment Letter 0000000000-24-011371 to NIKA PHARMACEUTICALS, INC (NIKA) (CIK 0001145604) (NIKA)
NIKA PHARMACEUTICALS, INC (NIKA) (CIK 0001145604)
Date: Oct. 8, 2024 · CIK: 0001145604 · Accession: 0000000000-24-011371
AI Filing Summary & Sentiment
File numbers found in text: 000-56234
Letter
October 8, 2024 Dimitar Slavchev Savov Chief Executive Officer Nika Pharmaceuticals, Inc. 2269 Merrimack Valley Avenue Henderson, NV 89044 Re:Nika Pharmaceuticals, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 000-56234 Dear Dimitar Slavchev Savov: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
October 8, 2024
Dimitar Slavchev Savov
Chief Executive Officer
Nika Pharmaceuticals, Inc.
2269 Merrimack Valley Avenue
Henderson, NV 89044
Re:Nika Pharmaceuticals, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 000-56234
Dear Dimitar Slavchev Savov:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences